← Leaderboards
Jens G Lohr
Dana-Farber Cancer Inst
$2,586,070
Attributed
$2,586,070
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $720.7K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,586,070 · 3
By mechanism
R37$1,146,267 · 1
K08$885,600 · 1
P01$554,203 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Irene M. Ghobrial$24,445,801
- Dan Landau$24,446,517
- Svitlana Tyekucheva$2,897,038
- Eliezer M Van Allen$14,227,870
- Peter Campbell$932,920
Others in their field
Top investigators on “Relapse”
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- Charles A Coltman · Southwest Oncology Group$124,514,512
- Mary M Horowitz · Medical College Of Wisconsin$85,160,686
- Monica M Bertagnolli · Strang Cancer Prevention Center$41,995,734
- Effie W Petersdorf · Fred Hutchinson Cancer Research Center$29,676,600
- Misty Ward Stevens · Intervexion Therapeutics, Llc$28,867,910
Research focus
RelapseGenomicsCellsMultiple MyelomaEvolutionBloodNeoplasm Circulating CellsRecurrent DiseaseResponseClinically RelevantMalignant NeoplasmsMonitorSiteBone MarrowDrug TargetingInsightDrug ResistanceBone Marrow BiopsyGeneticSuccessClinical CareMutationLaboratoriesCancer Genomics
Grant awards (10)
Liquid Biopsy in Myeloma to Inform Outcome and Treatment Decisions$352,275
R37 · FY2025 · CA · contact PI
Liquid biopsy in myeloma to inform outcome and treatment decisions$386,817
R37 · FY2024 · CA · contact PI
Core 4 - Genome Sequencing Core$240,658
P01 · FY2024 · CA · contact PI
Liquid biopsy in myeloma to inform outcome and treatment decisions$407,175
R37 · FY2023 · CA · contact PI
Core 4 - Genome Sequencing Core$313,545
P01 · FY2023 · CA · contact PI
Determining the mutational landscape of circulating multiple myeloma cells$177,120
K08 · FY2019 · CA · contact PI
Determining the mutational landscape of circulating multiple myeloma cells$177,120
K08 · FY2018 · CA · contact PI
Determining the mutational landscape of circulating multiple myeloma cells$177,120
K08 · FY2017 · CA · contact PI
Determining the mutational landscape of circulating multiple myeloma cells$177,120
K08 · FY2016 · CA · contact PI
Determining the mutational landscape of circulating multiple myeloma cells$177,120
K08 · FY2015 · CA · contact PI